An evaluation of MSDC-0160, a prototype mTOT modulating insulin sensitizer, in patients with mild Alzheimer's disease.
about
Discovery of Novel Insulin Sensitizers: Promising Approaches and Targets.The TZD insulin sensitizer clue provides a new route into diabetes drug discovery.Drugs in Clinical Trials for Alzheimer's Disease: The Major Trends.Mitochondrial pyruvate carrier regulates autophagy, inflammation, and neurodegeneration in experimental models of Parkinson's disease.Treating fatty liver disease by modulating mitochondrial pyruvate metabolism.
P2860
An evaluation of MSDC-0160, a prototype mTOT modulating insulin sensitizer, in patients with mild Alzheimer's disease.
description
2014 nî lūn-bûn
@nan
2014 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
An evaluation of MSDC-0160, a ...... with mild Alzheimer's disease.
@ast
An evaluation of MSDC-0160, a ...... with mild Alzheimer's disease.
@en
An evaluation of MSDC-0160, a ...... with mild Alzheimer's disease.
@nl
type
label
An evaluation of MSDC-0160, a ...... with mild Alzheimer's disease.
@ast
An evaluation of MSDC-0160, a ...... with mild Alzheimer's disease.
@en
An evaluation of MSDC-0160, a ...... with mild Alzheimer's disease.
@nl
prefLabel
An evaluation of MSDC-0160, a ...... with mild Alzheimer's disease.
@ast
An evaluation of MSDC-0160, a ...... with mild Alzheimer's disease.
@en
An evaluation of MSDC-0160, a ...... with mild Alzheimer's disease.
@nl
P2093
P2860
P1476
An evaluation of MSDC-0160, a ...... with mild Alzheimer's disease
@en
P2093
Ana W Capuano
Dawn C Matthews
Debra A Fleischman
James T VanderLugt
Jerry R Colca
Randolph D Andrews
P2860
P304
P356
10.2174/1567205011666140616113406
P50
P577
2014-01-01T00:00:00Z